{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T03:30:42Z","timestamp":1794886242503,"version":"4.9.1"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ygyno.2025.11.018","type":"journal-article","created":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T17:10:24Z","timestamp":1764868224000},"page":"158-164","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["First experience with intraperitoneal 224Ra-labeled microparticles after cytoreductive surgery in patients with peritoneal recurrence of platinum-sensitive epithelial ovarian cancer"],"prefix":"10.1016","volume":"204","author":[{"given":"Yun","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Els","family":"Van Nieuwenhuysen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona-Elisabeth","family":"Revheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe M.","family":"Deroose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ane Gerda Zahl","family":"Eriksson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brynhildur","family":"Eyjolfsdottir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toon","family":"Van Gorp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tha\u00efs","family":"Baert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Kirsti","family":"Aksnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kari","family":"Myren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignace","family":"Vergote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d8yvind S.","family":"Bruland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.ygyno.2025.11.018_bb0005","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1097\/IGC.0000000000000007","article-title":"Ovarian cancer: sites of recurrence","volume":"23","author":"Amate","year":"2013","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2025.11.018_bb0010","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1056\/NEJMoa2103294","article-title":"Randomized trial of cytoreductive surgery for relapsed ovarian cancer","volume":"385","author":"Harter","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.ygyno.2025.11.018_bb0015","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.suronc.2017.01.001","article-title":"Dealing with microscopic peritoneal metastases of epithelial ovarian cancer. A surgical challenge","volume":"26","author":"Aza\u00efs","year":"2017","journal-title":"Surg. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2025.11.018_bb0020","doi-asserted-by":"crossref","first-page":"102","DOI":"10.4251\/wjgo.v2.i2.102","article-title":"Peritoneal carcinosis of ovarian origin","volume":"2","author":"Fagotti","year":"2010","journal-title":"World J. Gastrointest. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2025.11.018_bb0025","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3390\/jcm10010041","article-title":"Microscopic peritoneal residual disease after complete macroscopic Cytoreductive surgery for advanced high grade serous ovarian cancer","volume":"10","author":"Aza\u00efs","year":"2021","journal-title":"J. Clin. Med."},{"issue":"2","key":"10.1016\/j.ygyno.2025.11.018_bb0030","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.tranon.2017.12.011","article-title":"Therapeutic effect of \u03b1-emitting 224Ra-labeled calcium carbonate microparticles in mice with intraperitoneal ovarian cancer","volume":"11","author":"Westr\u00f8m","year":"2018","journal-title":"Transl. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2025.11.018_bb0035","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/0090-8258(92)90141-5","article-title":"Therapeutic efficacy of the alpha-emitter 211At bound on microspheres compared with 90Y and 32P colloids in a murine intraperitoneal tumor model","volume":"47","author":"Vergote","year":"1992","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2025.11.018_bb0040","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/0090-8258(92)90140-E","article-title":"Distribution of intraperitoneally injected microspheres labeled with the alpha-emitter astatine (211At) compared with phosphorus (32P) and yttrium (90Y) colloids in mice","volume":"47","author":"Vergote","year":"1992","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2025.11.018_bb0045","unstructured":"European Medicines Agency (EMA) Guideline on Strategies to Identify and Mitigate Risks for First-in-human and Early Clinical Trials with Investigational Medicinal Products, EMEA\/ CHMP\/SWP\/28367\/07 Revision 1, n.d."},{"issue":"5","key":"10.1016\/j.ygyno.2025.11.018_bb0050","doi-asserted-by":"crossref","first-page":"634","DOI":"10.3390\/pharmaceutics13050634","article-title":"Improved formulation of 224Ra-labeled calcium carbonate microparticles by surface layer encapsulation and addition of EDTMP","volume":"13","author":"Li","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ygyno.2025.11.018_bb0055","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00393-005-0009-0","article-title":"Wirksamkeit und Vertr\u00e4glichkeit von Radiumchlorid in der Behandlung der ankylosierenden Spondylitis--Ergebnisse einer Anwendungsbeobachtung","volume":"65","author":"Alberding","year":"2006","journal-title":"Z. Rheumatol."},{"issue":"1","key":"10.1016\/j.ygyno.2025.11.018_bb0060","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/00006231-200201000-00010","article-title":"Renaissance of 224Ra for the treatment of ankylosing spondylitis: clinical experiences","volume":"23","author":"Tiepolt","year":"2002","journal-title":"Nucl. Med. Commun."},{"key":"10.1016\/j.ygyno.2025.11.018_bb0065","doi-asserted-by":"crossref","DOI":"10.3389\/fsurg.2022.976497","article-title":"Postoperative paralytic ileus following debulking surgery in ovarian cancer patients","volume":"9","author":"Egger","year":"2022","journal-title":"Front. Surg."},{"issue":"20","key":"10.1016\/j.ygyno.2025.11.018_bb0070","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1056\/NEJMoa1902626","article-title":"Secondary surgical cytoreduction for recurrent ovarian cancer","volume":"381","author":"Coleman","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.ygyno.2025.11.018_bb0075","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S1470-2045(21)00006-1","article-title":"Secondary cytoreduction followed by chemotherapy versus chemotherapy alone in platinum-sensitive relapsed ovarian cancer (SOC-1): a multicentre, open-label, randomised, phase 3 trial","volume":"22","author":"Shi","year":"2021","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ygyno.2025.11.018_bb0080","doi-asserted-by":"crossref","first-page":"1058914","DOI":"10.3389\/fmed.2023.1058914","article-title":"Radiation safety considerations for the use of radium-224 calciumcarbonate-microparticles in patients with peritoneal metastasis","volume":"10","author":"Gr\u00f8nnings\u00e6ter","year":"2023","journal-title":"Front. Med."},{"issue":"22","key":"10.1016\/j.ygyno.2025.11.018_bb0085","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.3390\/diagnostics13223484","article-title":"Prognosis following surgery for recurrent ovarian cancer and diagnostic criteria predictive of cytoreduction success: a systematic review and meta-analysis","volume":"13","author":"Gaba","year":"2023","journal-title":"Diagnostics (Basel)"},{"issue":"9","key":"10.1016\/j.ygyno.2025.11.018_bb0090","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1136\/ijgc-2023-004342","article-title":"Secondary cytoreduction in platinum sensitive relapsed ovarian cancer: an individual patient level meta-analysis","volume":"33","author":"Gulia","year":"2023","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2025.11.018_bb0095","article-title":"First experience with 224Radium-labeled microparticles (Radspherin\u00ae) after CRS-HIPEC for peritoneal metastasis in colorectal cancer (a phase 1 study)","volume":"10","author":"Larsen","year":"2023","journal-title":"Front. Med. (Lausanne)."},{"issue":"6","key":"10.1016\/j.ygyno.2025.11.018_bb0100","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1002\/jso.27897","article-title":"Eighteen-months safety and efficacy following intraperitoneal treatment with 224Radium-labeled microparticles after CRS-HIPEC in patients with peritoneal metastasis from colorectal cancer","volume":"130","author":"Larsen","year":"2024","journal-title":"J. Surg. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2025.11.018_bb0105","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/jso.24290","article-title":"Complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastasis in Norway: prognostic factors and oncologic outcome in a national patient cohort","volume":"114","author":"Fr\u00f8ysnes","year":"2016","journal-title":"J. Surg. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2025.11.018_bb0110","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S1470-2045(20)30599-4","article-title":"Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial","volume":"22","author":"Qu\u00e9net","year":"2021","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ygyno.2025.11.018_bb0115","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/978-1-4613-1247-5_23","article-title":"Clinical research methodologies in diagnosis and staging of patients with peritoneal Carcinomatosis","volume":"82","author":"Jacquet","year":"1996","journal-title":"Cancer Res. Treat."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825825011023?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825825011023?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T02:11:58Z","timestamp":1766110318000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825825011023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":23,"alternative-id":["S0090825825011023"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2025.11.018","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"First experience with intraperitoneal 224Ra-labeled microparticles after cytoreductive surgery in patients with peritoneal recurrence of platinum-sensitive epithelial ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2025.11.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}